Market Overview

Jim Cramer Advises His Viewers On Array Biopharma, GoPro & Sprint Corp

Related ARRY
Buy Sierra Oncology Ahead Of A 2018 Full Of Catalysts
Benzinga's Option Alert Recap From October 19
Related GPRO
Black Friday 2017: Everything You Need To Know
Lightning Round: Jim Cramer Advises His Viewers On Mallinckrodt, GoPro And More
GoPro: The Market Is Overly Pessimistic (Seeking Alpha)

On CNBC's Mad Money, Jim Cramer said that Array Biopharma Inc (NASDAQ: ARRY) is a very speculative stock and he would own something less speculative in the current market environment.

Cramer thinks that GoPro Inc (NASDAQ: GPRO) was really good when it had a tight flow, but now he just wants to move onto a different trade.

Sprint Corp (NYSE: S) won't move much higher in the near term, he said, because the government hasn't allowed a merger with T-Mobile US Inc (NYSE: TMUS).

Posted-In: Jim Cramer Mad MoneyCNBC Media


Related Articles (ARRY + GPRO)

View Comments and Join the Discussion!

Partner Center